Hepatitis b vaccines progressed from blood vaccines to recombinant vaccines , then to peptide vaccines and dna vaccines , to their functions extended from prophylactic to therapeutic 從第一代血源性疫苗到重組乙肝疫苗,再到合成肽疫苗和dna疫苗,乙肝疫苗的研制技術(shù)不斷進(jìn)步,其應(yīng)用范圍也已從預(yù)防擴展到治療。
So , recombinant vaccine of hp ( rhp } was used in this study . it has been proved that vaccine administered by mucosa can produce effective immune response and prevent or cure hp infection 幽門螺桿菌在粘膜部位感染機體,研究證實, hp疫苗經(jīng)粘膜途徑接種能產(chǎn)生有效的保護(hù)性免疫應(yīng)答,發(fā)揮預(yù)防、治療hp感染的作用。
The target protein purified by ni - nta metal chelate affinity presented one major band in the sds - page and reacted with rabbit serum raised against the ndv b95 strain in western blotting , suggested that the protein could be used as one of candidated antigenes . it provided the basis for further studying on recombinant vaccine against ndv 經(jīng)westem - bloting雜交實驗,純化出目的蛋白與兔抗ndvb95株抗體反應(yīng),說明表達(dá)產(chǎn)物確為ndvb95株hn蛋白,且具有一定的免疫原性,為進(jìn)一步研究重組疫苗創(chuàng)造了一定的條件。